IRW-News: Anixa Biosciences Inc.: Brief des CEO von Anixa Biosciences an die Aktionäre
IRW-PRESS: Anixa Biosciences Inc.: Brief des CEO von Anixa Biosciences an die AktionäreSAN JOSE, Kalifornien, 21. Januar 2025 / IRW-Press…
2,774$
15,09%
Echtzeit-Aktienkurs Anixa Biosciences
Bid:
Ask:
Nachrichten zur Anixa Biosciences Aktie
IRW-News: Anixa Biosciences Inc.: Brief des CEO von Anixa Biosciences an die Aktionäre
IRW-PRESS: Anixa Biosciences Inc.: Brief des CEO von Anixa Biosciences an die Aktionäre
SAN JOSE, Kalifornien, 21.…
H.C. Wainwright cuts Anixa Biosciences shares target amid financial performance By Investing.com
H.C. Wainwright cuts Anixa Biosciences shares target amid financial performance…
VENTYX NEWS NOTICE: Ventyx (Nasdaq: VTYX) Shareholders are Urged to Contact BFA Law about the Investigation into the Company’s Board of Directors
NEW YORK, June 08, 2024 (GLOBE NEWSWIRE) -- If you are a shareholder of Ventyx Biosciences (NASDAQ: VTYX),…
Spruce Biosciences und HMNC Brain Health kündigen strategische Zusammenarbeit zur Entwicklung einer Behandlung für Major Depressive Disorder (MDD) an
SOUTH SAN FRANCISCO, Kalifornien & MÜNCHEN--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB) („Spruce“), ein biopharmazeutisches Unternehmen im Spätstadium, das sich auf…
VENTYX SHAREHOLDER REMINDER: BFA Law Reminds Ventyx Biosciences, Inc. (NASDAQ: VTYX) Shareholders to Contact the Firm About Ongoing Investigation
NEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- If you are a shareholder of Ventyx Biosciences (NASDAQ: VTYX),…
INVESTIGATION ANNOUNCEMENT BFA LLP Announces an Ongoing Investigation into the Directors of Ventyx Biosciences, Inc. for Potential Breaches of Fiduciary Duty
NEW YORK, May 17, 2024 (GLOBE NEWSWIRE) -- If you are a shareholder of Ventyx Biosciences (NASDAQ: VTYX),…
Anixa Biosciences CEO Amit Kumar buys $96,600 in company stock By Investing.com
Anixa Biosciences CEO Amit Kumar buys $96,600 in company stock…
Anixa begins treatment of fourth patient in phase 1 ovarian cancer tiral By Investing.com
© Reuters. SAN JOSE, Calif. – Anixa Biosciences, Inc. (NASDAQ: NASDAQ:), a biotech company specializing in cancer treatment, has started…
Anixa Biosciences, Inc.: Could Anixa Biosciences Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?
SAN JOSE, CA / ACCESSWIRE / August 10, 2023 / Cancer is a disease that affects millions of people around…
Insiderhandel: Chief Executive Officer verkauft Aktien von Anixa Biosciences im Wert von 42.126$
Kumar, Amit - Vorstand - Tag der Transaktion: 2023-07-31...…
Insiderhandel: President, COO & CFO kauft Aktien von Anixa Biosciences im Wert von 20.020$
Catelani, Michael - Vorstand - Tag der Transaktion: 2023-07-20...…
6 Analysts Have This to Say About Anixa Biosciences
Latest Ratings for ANIX
DateFirmActionFromTo Apr 2021HC Wainwright & Co.Initiates Coverage OnBuy Mar 2020Aegis CapitalInitiates Coverage OnBuy Dec 2019B.…
Anixa (ANIX) Falls 25% Despite Positive Breast Cancer Study Data
Anixa Biosciences (ANIX) announces positive top-line data from its phase Ia study evaluating the safety of its breast cancer vaccine.…
Form 8-K Anixa Biosciences Inc For: Apr 17
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 10-Q Anixa Biosciences Inc For: Jan 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…